The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control

被引:270
作者
Garkavtsev, I
Grigorian, IA
Ossovskaya, VS
Chernov, MV
Chumakov, PM
Gudkov, AV [1 ]
机构
[1] Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA
[2] Univ Calgary, Dept Med Biochem, Calgary, AB T2N 4N1, Canada
[3] Univ Calgary, So Alberta Canc Res Ctr, Calgary, AB T2N 4N1, Canada
[4] VA Engelhardt Mol Biol Inst, Moscow 117984, Russia
[5] Cleveland Clin Fdn, Cleveland, OH 44195 USA
关键词
D O I
10.1038/34675
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The candidate tumour-suppressor gene ING1 has been identified by using the genetic suppressor element (GSE) methodology(1). ING1 encodes a nuclear protein, p33(ING1), overexpression of which inhibits growth of different cell lines. The properties of p33(ING1) suggest its involvement in the negative regulation of cell proliferation and in the control of cellular ageing, anchorage dependence and apoptosis(1-3). These cellular functions depend largely on the activity of p53, a tumour-suppressor gene that determines the cellular response to various types of stress(4). Here we report that the biological effects of ING1 and p53 are interrelated and require the activity of both genes: neither of the two genes can, on its own, cause growth inhibition when the other one is suppressed. Furthermore, activation of transcription from the P21/WAF1 promoter, a key mechanism of p53-mediated growth control, depends on the expression of ING1. A physical association between p33(ING1) and p53 proteins has been detected by immunoprecipitation. These results indicate that p33(ING1) is a component of the p53 signalling pathway that cooperates with p53 in the negative regulation of cell proliferation by modulating p53-dependent transcriptional activation.
引用
收藏
页码:295 / 298
页数:4
相关论文
共 18 条
[1]   P53 CONTROLS BOTH THE G(2)/M AND THE G(1) CELL-CYCLE CHECKPOINTS AND MEDIATES REVERSIBLE GROWTH ARREST IN HUMAN FIBROBLASTS [J].
AGARWAL, ML ;
AGARWAL, A ;
TAYLOR, WR ;
STARK, GR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (18) :8493-8497
[2]   Recruitment of p300/CBP in p53-dependent signal pathways [J].
Avantaggiati, ML ;
Ogryzko, V ;
Gardner, K ;
Giordano, A ;
Levine, AS ;
Kelly, K .
CELL, 1997, 89 (07) :1175-1184
[3]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[4]   Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33(ING1) candidate tumor suppressor [J].
Garkavtsev, I ;
Riabowol, K .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :2014-2019
[5]   Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1) [J].
Garkavtsev, I ;
Demetrick, D ;
Riabowol, K .
CYTOGENETICS AND CELL GENETICS, 1997, 76 (3-4) :176-178
[6]   Suppression of the novel growth inhibitor p33(ING1) promotes neoplastic transformation [J].
Garkavtsev, I ;
Kazarov, A ;
Gudkov, A ;
Riabowol, K .
NATURE GENETICS, 1996, 14 (04) :415-420
[7]   p53 in growth control and neoplasia [J].
Gottlieb, TM ;
Oren, M .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1996, 1287 (2-3) :77-102
[8]   P53 ALTERATION IS A COMMON EVENT IN THE SPONTANEOUS IMMORTALIZATION OF PRIMARY BALB/C MURINE EMBRYO FIBROBLASTS [J].
HARVEY, DM ;
LEVINE, AJ .
GENES & DEVELOPMENT, 1991, 5 (12B) :2375-2385
[9]  
Helbing CC, 1997, CANCER RES, V57, P1255
[10]   Identification of redox/repair protein Ref-1 as a potent activator of p53 [J].
Jayaraman, L ;
Murthy, KGK ;
Zhu, C ;
Curran, T ;
Xanthoudakis, S ;
Prives, C .
GENES & DEVELOPMENT, 1997, 11 (05) :558-570